In individuals with malabsorption disorders, the metabolism of drugs and other chemicals can be significantly altered. Poor absorption in the gut may lead to reduced bioavailability of oral medications, necessitating adjustments in dosing. Additionally, changes in gut microbiota associated with malabsorption disorders can affect the metabolism of drugs, potentially leading to unexpected side effects or reduced efficacy.